Delivery Order SPE2DB22D3501-SPE2DB26FTL15
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for LENVIMA 14 mg daily dose (60-count supply) on August 14, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. LENVIMA is a targeted cancer therapy medication, and this procurement supports...
- The Defense Logistics Agency (DLA) awarded a $10,223.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 20 MG daily dose (60-count supply) with an ultimate completion date of August 19, 2025. This non-set-aside competitive award was issued on July 29, 2025, with performance to be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. LENVIMA is a targeted cancer therapy medication, reflecting the federal government's continued reliance on...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of LENVIMA 8 mg daily dose tablets (60-count units) under a firm fixed-price contract valued at $21,547.44. This competitively awarded, non-set-aside delivery order has an ultimate completion date of November 26, 2025, and is being fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen...
- The Defense Logistics Agency awarded a $10,223.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 10 mg daily dose tablets (30-count package) with an ultimate completion date of August 19, 2025. This non-competitive delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. LENVIMA is a targeted cancer therapy indicated for multiple malignancies, and this award reflects...
- The Defense Logistics Agency awarded a $10,223.24 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Lenvima 10 mg daily dose medication in 30-day quantities. This is a firm fixed price delivery order with no set-aside designation, scheduled for ultimate completion by September 3, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for LENVIMA 14 mg daily dose, 60-count units. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, scheduled for completion by August 5, 2025. The award was issued on July 15, 2025, and the product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Lenvima 8 mg daily dose tablets (60-count) with a ceiling value of $10,223.24. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for completion by November 26, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a $10,223.24 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Lenvima 8 mg daily dose in quantities of 60 units. The order is a firm fixed price delivery order with an ultimate completion date of November 18, 2025, and represents a non-competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its Corporate Office location. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,910.95 to AmerisourceBergen Drug Corp for the supply of LENVIMA 18 mg daily dose in a 90-day supply. The contract, executed on April 24, 2025, with completion targeted for May 15, 2025, utilizes a firm fixed price structure with no set-aside designation, indicating competitive award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for LENVIMA 10 MG daily dose tablets (30-count supply). This firm fixed-price, non-set-aside contract was awarded on August 18, 2025, with an ultimate completion date of September 9, 2025. LENVIMA (lenvatinib) is a targeted cancer therapy used to treat various malignancies, reflecting the pharmaceutical distributor's role in supplying specialized oncology medications to federal...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTL15Delivery Order
The Defense Logistics Agency awarded a $10,223.24 delivery order to AmerisourceBergen Drug Corp for LENVIMA 10 mg daily dose medication (30-count supply) on November 7, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is being fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The contract supports federal medical procurement needs within the military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal contracts covering a wide spectrum of medications across multiple therapeutic domains and demonstrates significant capability in fulfilling federal medical supply requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 11/7/25 |